| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 96.872 | 171.988 | 160.505 | 327.192 | 261.116 | 443.309 | 347.090 | 439.725 | 528.864 |
| Total Income - EUR | - | 96.872 | 171.988 | 160.505 | 327.320 | 264.133 | 443.653 | 347.561 | 441.534 | 557.899 |
| Total Expenses - EUR | - | 8.484 | 36.842 | 58.907 | 73.961 | 78.114 | 100.832 | 93.377 | 99.877 | 163.970 |
| Gross Profit/Loss - EUR | - | 88.388 | 135.146 | 101.598 | 253.359 | 186.020 | 342.821 | 254.184 | 341.657 | 393.929 |
| Net Profit/Loss - EUR | - | 87.088 | 133.425 | 99.992 | 250.086 | 183.557 | 338.472 | 250.777 | 337.330 | 333.776 |
| Employees | - | 4 | 3 | 3 | 4 | 3 | 4 | 4 | 3 | 4 |
Check the financial reports for the company - Oncoplastica Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 42.094 | 30.809 | 19.280 | 9.974 | 2.124 | 2.196 | 5.759 | 59.602 |
| Current Assets | - | 90.624 | 180.213 | 141.655 | 237.712 | 307.079 | 435.411 | 258.342 | 337.370 | 297.523 |
| Inventories | - | 0 | 0 | 446 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 2.757 | 73.695 | 4.168 | 1.121 | 1.500 | 1.635 | 1.835 |
| Cash | - | 90.624 | 180.213 | 138.452 | 164.017 | 302.911 | 434.290 | 256.842 | 335.735 | 295.688 |
| Shareholders Funds | - | 87.311 | 219.259 | 165.738 | 250.339 | 306.474 | 428.454 | 251.021 | 337.573 | 334.018 |
| Social Capital | - | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 3.313 | 3.772 | 6.858 | 6.836 | 10.882 | 9.081 | 9.786 | 7.107 | 23.107 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncoplastica Med Srl